Logo image of TRX

TRX GOLD CORP (TRX) Stock Fundamental Analysis

NYSEARCA:TRX - NYSE Arca - CA87283P1099 - Common Stock - Currency: USD

0.3364  -0.02 (-4.94%)

Premarket: 0.3452 +0.01 (+2.62%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to TRX. TRX was compared to 156 industry peers in the Metals & Mining industry. There are concerns on the financial health of TRX while its profitability can be described as average. TRX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

TRX had negative earnings in the past year.
In the past year TRX had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: TRX reported negative net income in multiple years.
In multiple years TRX reported negative operating cash flow during the last 5 years.
TRX Yearly Net Income VS EBIT VS OCF VS FCFTRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

TRX has a Return On Assets (0.08%) which is comparable to the rest of the industry.
The Return On Equity of TRX (0.16%) is comparable to the rest of the industry.
The Return On Invested Capital of TRX (9.83%) is better than 85.90% of its industry peers.
TRX had an Average Return On Invested Capital over the past 3 years of 8.16%. This is below the industry average of 10.98%.
The last Return On Invested Capital (9.83%) for TRX is above the 3 year average (8.16%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.08%
ROE 0.16%
ROIC 9.83%
ROA(3y)2.9%
ROA(5y)-5.69%
ROE(3y)4.91%
ROE(5y)-7.86%
ROIC(3y)8.16%
ROIC(5y)N/A
TRX Yearly ROA, ROE, ROICTRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

The Profit Margin of TRX (0.19%) is comparable to the rest of the industry.
TRX has a Operating Margin of 22.46%. This is in the better half of the industry: TRX outperforms 76.92% of its industry peers.
TRX's Gross Margin of 39.46% is amongst the best of the industry. TRX outperforms 81.41% of its industry peers.
Industry RankSector Rank
OM 22.46%
PM (TTM) 0.19%
GM 39.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TRX Yearly Profit, Operating, Gross MarginsTRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

TRX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, TRX has more shares outstanding
TRX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, TRX has a worse debt to assets ratio.
TRX Yearly Shares OutstandingTRX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
TRX Yearly Total Debt VS Total AssetsTRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of 0.17, we must say that TRX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.17, TRX is not doing good in the industry: 81.41% of the companies in the same industry are doing better.
TRX has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.04, TRX is in the better half of the industry, outperforming 69.87% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 0.17
ROIC/WACC1.25
WACC7.84%
TRX Yearly LT Debt VS Equity VS FCFTRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

A Current Ratio of 0.77 indicates that TRX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.77, TRX is doing worse than 89.10% of the companies in the same industry.
TRX has a Quick Ratio of 0.77. This is a bad value and indicates that TRX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.40, TRX is doing worse than 91.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.4
TRX Yearly Current Assets VS Current LiabilitesTRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

3

3. Growth

3.1 Past

TRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -98.18%.
Looking at the last year, TRX shows a very strong growth in Revenue. The Revenue has grown by 26.48%.
EPS 1Y (TTM)-98.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-230.3%
Revenue 1Y (TTM)26.48%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%14.07%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue is expected to grow by 27.51% on average over the next years. This is a very strong growth
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year28.85%
Revenue Next 2Y27.51%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
TRX Yearly Revenue VS EstimatesTRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2022 2023 2024 2025 2026 20M 40M 60M
TRX Yearly EPS VS EstimatesTRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 0.02 -0.02 0.04 0.06

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TRX. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 5.12, which indicates a rather cheap valuation of TRX.
Based on the Price/Forward Earnings ratio, TRX is valued cheaper than 94.23% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.46, TRX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 5.12
TRX Price Earnings VS Forward Price EarningsTRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

TRX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. TRX is cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.07
TRX Per share dataTRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TRX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TRX GOLD CORP

NYSEARCA:TRX (6/24/2025, 8:04:00 PM)

Premarket: 0.3452 +0.01 (+2.62%)

0.3364

-0.02 (-4.94%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-14 2025-04-14/amc
Earnings (Next)07-10 2025-07-10/amc
Inst Owners2.12%
Inst Owner Change-2.38%
Ins Owners1.45%
Ins Owner ChangeN/A
Market Cap94.97M
Analysts80
Price Target1.22 (262.66%)
Short Float %0.05%
Short Ratio0.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-149.5%
Min EPS beat(2)-199.01%
Max EPS beat(2)-100%
EPS beat(4)0
Avg EPS beat(4)-137.13%
Min EPS beat(4)-199.01%
Max EPS beat(4)-50.49%
EPS beat(8)0
Avg EPS beat(8)-118.56%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-21.19%
Min Revenue beat(2)-34.44%
Max Revenue beat(2)-7.94%
Revenue beat(4)0
Avg Revenue beat(4)-22.05%
Min Revenue beat(4)-34.44%
Max Revenue beat(4)-7.94%
Revenue beat(8)0
Avg Revenue beat(8)-20.48%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-18.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.12
P/S 2.09
P/FCF N/A
P/OCF 7.01
P/B 1.74
P/tB 1.74
EV/EBITDA 7.07
EPS(TTM)-0.01
EYN/A
EPS(NY)0.07
Fwd EY19.52%
FCF(TTM)0
FCFYN/A
OCF(TTM)0.05
OCFY14.27%
SpS0.16
BVpS0.19
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.08%
ROE 0.16%
ROCE 12.44%
ROIC 9.83%
ROICexc 10.74%
ROICexgc 10.74%
OM 22.46%
PM (TTM) 0.19%
GM 39.46%
FCFM N/A
ROA(3y)2.9%
ROA(5y)-5.69%
ROE(3y)4.91%
ROE(5y)-7.86%
ROIC(3y)8.16%
ROIC(5y)N/A
ROICexc(3y)9.9%
ROICexc(5y)N/A
ROICexgc(3y)10.18%
ROICexgc(5y)N/A
ROCE(3y)10.33%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA 0.16
Cap/Depr 498.66%
Cap/Sales 31.09%
Interest Coverage 250
Cash Conversion 104.03%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.4
Altman-Z 0.17
F-Score4
WACC7.84%
ROIC/WACC1.25
Cap/Depr(3y)4701.66%
Cap/Depr(5y)4096.58%
Cap/Sales(3y)58.87%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-98.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-230.3%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.48%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%14.07%
Revenue Next Year28.85%
Revenue Next 2Y27.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y41.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1622.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.23%
OCF growth 3YN/A
OCF growth 5YN/A